<bill session="116" type="s" number="3384" updated="2022-02-08T23:23:00Z">
  <state datetime="2020-03-03">REFERRED</state>
  <status>
    <introduced datetime="2020-03-03"/>
  </status>
  <introduced datetime="2020-03-03"/>
  <titles>
    <title type="display">Lowering Prescription Drug Prices for America&#226;&#8364;&#8482;s Seniors and Families Act of 2020</title>
    <title type="short" as="introduced">Lowering Prescription Drug Prices for America&#226;&#8364;&#8482;s Seniors and Families Act of 2020</title>
    <title type="official" as="introduced">A bill to allow for negotiation of prices for certain covered Medicare part D drugs, to allow for importation by individuals of prescription drugs from Canada, to preserve access to affordable generics and biosimilars, to increase the use of real-time benefit tools to lower beneficiary costs, to establish a manufacturer discount program, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001197"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-03-03">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-03-03" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="478" relation="unknown"/>
    <bill session="116" type="h" number="2374" relation="unknown"/>
    <bill session="116" type="h" number="2455" relation="unknown"/>
    <bill session="116" type="s" number="61" relation="unknown"/>
    <bill session="116" type="s" number="64" relation="unknown"/>
    <bill session="116" type="s" number="1169" relation="unknown"/>
    <bill session="116" type="s" number="1224" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Administrative remedies"/>
    <term name="Business ethics"/>
    <term name="Canada"/>
    <term name="Civil actions and liability"/>
    <term name="Competition and antitrust"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Federal Trade Commission (FTC)"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Inflation and prices"/>
    <term name="Intellectual property"/>
    <term name="Licensing and registrations"/>
    <term name="Manufacturing"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public participation and lobbying"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary date="2021-01-11T22:09:46Z" status="Introduced in Senate">Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020

This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare &amp; Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.</summary>
</bill>
